EYPT EyePoint, Inc. - Common Stock
$5.96
가격 · 8월 19, 2026
기준 재무 정보 8월 5, 2026
52주 범위
$4–$19
13% of range
애널리스트 평점
BUY
20 analysts
목표 주가
$37
+514% upside
P/E (TTM)
-1.9
ROE
-84.0%
순이익률
-739.4%
EyePoint, Inc. - Common Stock 정보 위키백과 회사 개요
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
더 보기
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
EYPT 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$5.96
시가총액
$494M
P/E (TTM)
-1.9
EPS (TTM)
$-3.17
매출 (TTM)
$31M
배당 수익률
—
ROE
-84.0%
부채/자본
—
52주 범위
$4 – $19
EYPT 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$31M
2017-06-30
→
2025-12-31
EPS
$-3.17
2017-06-30
→
2025-12-31
잉여현금흐름
$-243M
2019-12-31
→
2025-12-31
마진
-739.4%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
EYPT
동종업계 중앙값
P/E (TTM)
-1.9
29.9
P/S (TTM)
15.7
14.4
P/B
1.6
4.4
Price / FCF (주가 / FCF)
-2.0
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
EYPT
동종업계 중앙값
Operating Margin (영업이익률)
-776.0%
—
Net Profit Margin (순이익률)
-739.4%
0.70%
ROA
-59.3%
-0.55%
ROE
-84.0%
-2.5%
ROIC
-79.6%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
EYPT
동종업계 중앙값
Current Ratio (유동비율)
8.9
3.9
Quick Ratio (당좌 비율)
8.3
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
EYPT
동종업계 중앙값
Revenue YoY (매출 YoY)
-27.5%
—
Revenue CAGR 3Y (매출 CAGR 3년)
-8.8%
—
Revenue CAGR 5Y (매출 CAGR 5년)
-1.8%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
EYPT
동종업계 중앙값
EYPT 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
20 명의 애널리스트
- 적극 매수 7 35.0%
- 매수 12 60.0%
- 보유 1 5.0%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
13 명의 애널리스트 · 2026-08-19
중앙값
$37.00
← 모든 목표가 하회
$5.96
저가
$8.00
고가
$68.00
중앙값 목표
$37.00
+520.8%
평균 목표
$36.62
+514.4%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.07%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-1.09 | $-0.97 | -0.12% |
| 2026년 3월 31일 | $-0.99 | $-0.82 | -0.17% |
| 2025년 12월 31일 | $-0.81 | $-0.76 | -0.05% |
| 2025년 9월 30일 | $-0.85 | $-0.80 | -0.05% |
| 2025년 6월 30일 | $-0.85 | $-0.81 | -0.04% |
| 2025년 3월 31일 | $-0.65 | $-0.67 | 0.02% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | — |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| AVIR | $279M | -1.8 | — | — | -49.5% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31M | $43M | $46M | $41M | $37M | $34M | $20M | $5M | $8M | $2M | $27M | |
| R&D Expense | $221M | $133M | $65M | $50M | $28M | $17M | $15M | $19M | $15M | $14M | $12M | |
| SG&A Expense | $52M | $52M | $40M | $35M | $26M | $21M | $18M | $15M | $11M | $9M | $8M | |
| Operating Expenses | $275M | $189M | $121M | $141M | $92M | $72M | $68M | $44M | $26M | $23M | $20M | |
| Operating Income | $-243M | $-146M | $-75M | $-100M | $-55M | $-37M | $-48M | $-39M | $-19M | $-22M | $6M | |
| Interest Expense | · | · | $1M | $3M | $5M | $7M | $6M | $2M | $0 | $0 | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $19.0K | |
| Other Non-op | $12M | $15M | $7M | $2M | $292.0K | $58.0K | $1M | $420.0K | $91.0K | $72.0K | $22.0K | |
| Pretax Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Income Tax | $279.0K | $90.0K | $83.0K | · | $0 | $0 | $0 | · | $0 | $-155.0K | $96.0K | |
| Net Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | $-86M | $-18M | $-22M | $6M | |
| EPS (Basic) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.22 | |
| EPS (Diluted) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.21 | |
| Shares (Basic) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 29,378,250 | |
| Shares (Diluted) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 30,584,140 | |
| EBITDA | $-241M | $-146M | $-75M | $-100M | $-55M | · | $-48M | · | · | $-22M | $6M |
대차대조표 27
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $100M | $281M | $96M | $179M | $45M | $22M | $45M | $17M | $15M | $19M | |
| Short-term Investments | $204M | $271M | $50M | $49M | $33M | $0 | $0 | $0 | $0 | $14M | $9M | |
| Inventory | $2M | $2M | $4M | $3M | $4M | $5M | $2M | $279.0K | · | · | · | |
| Prepaid Expense | $20M | $9M | $9M | $10M | $4M | $3M | $6M | $1M | $591.0K | $483.0K | $681.0K | |
| Other Current Assets | $2M | $1M | $1M | $782.0K | $517.0K | · | · | · | · | · | · | |
| Current Assets | $329M | $383M | $345M | $173M | $238M | $63M | $42M | $48M | $18M | $30M | $30M | |
| PP&E (Net) | $9M | $8M | $5M | $1M | $476.0K | $630.0K | $357.0K | $288.0K | $313.0K | $290.0K | $338.0K | |
| PP&E (Gross) | $15M | $12M | $8M | $3M | $2M | $2M | $1M | $983.0K | $799.0K | $2M | $2M | |
| Accum. Depreciation | $6M | $4M | $3M | $2M | $1M | $1M | $839.0K | $695.0K | $486.0K | $2M | $2M | |
| Intangibles | · | · | · | $0 | $23M | $25M | $28M | $30M | $364.0K | $1M | $2M | |
| Other Non-current Assets | $6M | $6M | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Accounts Payable | $10M | $12M | $7M | $6M | $7M | $5M | $4M | $3M | $1M | $1M | $744.0K | |
| Accrued Liabilities | $24M | $18M | $18M | $16M | $14M | $8M | $7M | $4M | $4M | $4M | $3M | |
| Short-term Debt | · | · | $0 | $10M | $0 | · | · | · | · | · | · | |
| Current Liabilities | $37M | $49M | $63M | $35M | $24M | $15M | $12M | $21M | $5M | $5M | $3M | |
| Capital Leases | $21M | $22M | $5M | $6M | $2M | $2M | $3M | $0 | · | · | · | |
| Other Non-current Liabilities | $87.0K | $205.0K | $0 | $600.0K | $2M | $2M | $3M | $1M | $51.0K | · | · | |
| Total Liabilities | $58M | $82M | $89M | $84M | $79M | $73M | $65M | $41M | $5M | $11M | $9M | |
| Long-term Debt | · | · | · | $30M | · | · | · | · | · | · | · | |
| Total Debt | · | · | $0 | $40M | $37M | · | $47M | · | · | · | · | |
| Common Stock | $83.0K | $68.0K | $49.0K | $34.0K | $34.0K | $18.0K | $11.0K | $95.0K | $39.0K | $34.0K | $29.0K | |
| Retained Earnings | $-1.10B | $-873M | $-742M | $-671M | $-569M | $-511M | $-465M | $-408M | $-311M | $-292M | $-271M | |
| AOCI | $961.0K | $1M | $864.0K | $786.0K | $841.0K | $841.0K | $840.0K | $839.0K | $833.0K | $852.0K | $945.0K | |
| Stockholders' Equity | $306M | $337M | $266M | $96M | $184M | $19M | $8M | $38M | $13M | $21M | $23M | |
| Liabilities + Equity | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Shares Outstanding | 82,826,416 | 68,266,005 | 49,043,074 | 34,082,934 | 33,905,826 | 18,139,981 | 10,941,659 | 95,372,236 | 39,356,999 | 34,172,919 | 29,412,365 |
현금 흐름 18
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $464.0K | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $28M | $37M | $12M | $14M | $7M | $6M | $5M | · | $2M | $2M | $2M | |
| Deferred Tax | $279.0K | $90.0K | $83.0K | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $0 | $2M | $2M | $2M | $2M | $981.0K | $724.0K | $756.0K | $770.0K | |
| Restructuring | · | · | · | · | · | $590.0K | · | · | $472.0K | · | · | |
| Other Non-cash | $-39M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-240M | $-126M | $2M | $-65M | $-50M | $-14M | $-57M | · | $-20M | $-16M | $10M | |
| CapEx | $3M | $4M | $3M | $2M | $156.0K | $362.0K | $213.0K | · | $147.0K | $113.0K | $161.0K | |
| Investing Cash Flow | $69M | $-219M | $-3M | $-17M | $-33M | $-362.0K | $-213.0K | · | $14M | $-4M | · | |
| Debt Issued | · | · | $0 | $30M | $0 | · | $50M | · | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $-30M | $-8M | $0 | · | $30M | · | · | · | · | |
| Stock Issued | $173M | $163M | $226M | $0 | · | $50M | $23M | · | $8M | $16M | $0 | |
| Net Stock Activity | $173M | $163M | $226M | · | · | · | $23M | · | · | $16M | · | |
| Financing Cash Flow | $174M | $164M | $187M | $-690.0K | $217M | $37M | $34M | · | $9M | $17M | · | |
| Net Change in Cash | $2M | $-182M | $186M | $-83M | $134M | $23M | $-23M | · | $2M | $-4M | $4M | |
| Taxes Paid | $200.0K | $100.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-243M | $-130M | $-2M | $-67M | $-50M | · | $-57M | · | · | $-16M | $10M | |
| Levered FCF | · | · | $-3M | $-70M | $-56M | · | $-63M | · | · | · | · |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| Net Margin | -739.4% | -302.4% | -153.8% | -247.0% | -158.1% | · | -278.9% | · | · | -1330.1% | 23.9% | |
| Pretax Margin | -738.5% | -302.2% | -153.7% | -247.0% | -158.1% | · | -278.9% | · | · | -1339.6% | 24.2% | |
| EBITDA Margin | -768.6% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| ROA | -59.3% | -33.8% | -26.4% | -46.1% | -32.9% | · | -75.1% | · | · | -67.3% | 23.1% | |
| ROE | -84.0% | -47.1% | -43.6% | -87.9% | -42.2% | · | -468.1% | · | · | -90.8% | 24.8% | |
| ROIC | -79.6% | -43.4% | -28.2% | -73.2% | -25.0% | · | -86.2% | · | · | -103.5% | 27.1% |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 | · | 3.6 | · | · | 5.9 | 8.9 | |
| Quick Ratio | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 | · | 1.9 | · | · | 5.7 | 8.5 | |
| Debt / Equity | · | · | 0.0 | 0.4 | 0.2 | · | 5.7 | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.3 | 0.2 | · | 5.7 | · | · | · | · | |
| Interest Coverage | · | · | -60.2 | -31.2 | -10.1 | · | -7.7 | · | · | · | · |
효율성 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | · | 0.3 | · | · | 0.1 | 1.0 |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -27.5% | -6.0% | 11.1% | 12.1% | 7.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -8.8% | 5.4% | 10.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $31M | $43M | $46M | $41M | $37M | $34M | $20M | · | $8M | $2M | $27M | |
| Net Income TTM | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Market Cap | $1.51B | $509M | $1.13B | $119M | $415M | · | $1.70B | · | · | $967M | $1.11B | |
| Enterprise Value | · | · | $802M | $15M | $240M | · | $1.72B | · | · | · | · | |
| P/E | -5.8 | -3.2 | -12.7 | -1.3 | -6.0 | -9.8 | -23.1 | · | -32.9 | -41.6 | 179.5 | |
| P/S | 48.2 | 11.8 | 24.6 | 2.9 | 11.2 | · | 83.3 | · | · | 597.0 | 41.7 | |
| P/B | 4.9 | 1.5 | 4.3 | 1.2 | 2.3 | · | 203.6 | · | · | 46.3 | 47.5 | |
| P / Tangible Book | 4.9 | 1.5 | 4.3 | 1.2 | 2.6 | · | · | · | · | · | · | |
| P / Cash Flow | -6.3 | -4.0 | 604.5 | -1.8 | -8.3 | · | -29.9 | · | · | -59.3 | 107.7 | |
| P / FCF | -6.2 | -3.9 | -704.8 | -1.8 | -8.3 | · | -29.8 | · | · | -58.9 | 109.4 | |
| EV / EBITDA | · | · | -10.7 | -0.1 | -4.3 | · | -36.0 | · | · | · | · | |
| EV / FCF | · | · | -499.0 | -0.2 | -4.8 | · | -30.2 | · | · | · | · | |
| EV / Revenue | · | · | 17.4 | 0.4 | 6.5 | · | 84.5 | · | · | · | · | |
| Earnings Yield | -17.3% | -31.1% | -7.9% | -78.3% | -16.6% | -10.2% | -4.3% | · | -3.0% | -2.4% | 0.56% |
손익계산서 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $507.0K | $696.0K | $619.0K | $966.0K | $5M | $24M | $12M | $11M | $9M | $12M | $14M | $15M | $9M | $8M | $11M | $10M | |
| Cost of Revenue | · | · | · | · | · | · | · | $736.0K | $1M | $759.0K | · | $1M | $2M | $640.0K | · | · | |
| R&D Expense | $84M | $72M | $59M | $48M | $55M | $59M | $43M | $30M | $30M | $30M | $18M | $17M | $16M | $14M | $16M | $11M | |
| SG&A Expense | $14M | $15M | $11M | $14M | $12M | $14M | $13M | $13M | $13M | $14M | $11M | $11M | $9M | $9M | $8M | $9M | |
| Operating Expenses | $98M | $88M | $71M | $63M | $68M | $73M | $57M | $43M | $44M | $45M | $30M | $30M | $32M | $29M | $54M | $28M | |
| Operating Income | $-97M | $-87M | $-70M | $-62M | $-62M | $-49M | $-45M | $-33M | $-35M | $-33M | $-16M | $-14M | $-23M | $-22M | $-44M | $-18M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $435.0K | $812.0K | $781.0K | $662.0K | |
| Other Non-op | $3M | $2M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $2M | $2M | $2M | $1M | $1M | $640.0K | |
| Pretax Income | $-94M | · | $-67M | $-60M | $-59M | · | $-41M | $-29M | $-31M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $-50.0K | $186.0K | $0 | $93.0K | $0 | $90.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-94M | $-85M | $-68M | $-60M | $-59M | $-45M | $-41M | $-29M | $-31M | $-29M | $-14M | $-13M | $-23M | $-21M | $-43M | $-18M | |
| EPS (Basic) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| EPS (Diluted) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| Shares (Basic) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| Shares (Diluted) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| EBITDA | $-97M | $-87M | · | $-62M | $-62M | $-49M | · | $-33M | $-35M | $-33M | · | $-14M | $-23M | $-22M | · | $-18M |
대차대조표 27
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $78M | $102M | $75M | $71M | $85M | $100M | $80M | $91M | $271M | $281M | $133M | $140M | $106M | $96M | $75M | |
| Short-term Investments | $70M | $145M | $204M | $129M | $185M | $233M | $271M | $174M | $189M | $28M | $50M | $3M | $3M | $17M | $49M | $82M | |
| Inventory | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | |
| Prepaid Expense | $6M | $25M | $20M | $9M | $6M | $6M | $9M | $12M | $10M | $11M | $9M | $9M | $9M | $9M | $10M | $10M | |
| Other Current Assets | $987.0K | $1M | $2M | $899.0K | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $549.0K | $0 | $0 | $782.0K | · | |
| Current Assets | $189M | $250M | $329M | $216M | $265M | $327M | $383M | $269M | $295M | $318M | $345M | $150M | $167M | $146M | $173M | $192M | |
| PP&E (Net) | $10M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $1M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $12M | · | · | · | $8M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $6M | · | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | |
| Other Non-current Assets | $9M | $9M | $6M | $6M | $6M | $6M | $6M | $2M | · | · | $0 | · | · | · | · | · | |
| Total Assets | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Accounts Payable | $17M | $19M | $10M | $10M | $20M | $16M | $12M | $7M | $14M | $7M | $7M | $10M | $11M | $9M | $6M | $6M | |
| Accrued Liabilities | $22M | $16M | $24M | $18M | $11M | $18M | $18M | $14M | $13M | $16M | $18M | $13M | $15M | $10M | $16M | $16M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $5M | $10M | $10M | |
| Current Liabilities | $42M | $37M | $37M | $30M | $33M | $42M | $49M | $49M | $62M | $63M | $63M | $64M | $69M | $27M | $35M | $34M | |
| Capital Leases | $20M | $20M | $21M | $21M | $22M | $22M | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Other Non-current Liabilities | $23.0K | $55.0K | $87.0K | $118.0K | $148.0K | $177.0K | $205.0K | $233.0K | · | · | $0 | $0 | $0 | $600.0K | $600.0K | $600.0K | |
| Total Liabilities | $62M | $58M | $58M | $52M | $55M | $64M | $82M | $82M | $96M | $79M | $89M | $101M | $118M | $76M | $84M | $84M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | · | $30M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $35M | · | $40M | |
| Common Stock | $85.0K | $83.0K | $83.0K | $70.0K | $69.0K | $69.0K | $68.0K | $53.0K | $52.0K | $50.0K | $49.0K | $35.0K | $34.0K | $34.0K | $34.0K | $34.0K | |
| Retained Earnings | $-1.28B | $-1.19B | $-1.10B | $-1.04B | $-978M | $-918M | $-873M | $-832M | $-802M | $-771M | $-742M | $-728M | $-715M | $-693M | $-671M | $-628M | |
| AOCI | $793.0K | $802.0K | $961.0K | $919.0K | $832.0K | $923.0K | $1M | $1M | $792.0K | $836.0K | $864.0K | $841.0K | $842.0K | $843.0K | $786.0K | $653.0K | |
| Stockholders' Equity | $166M | $230M | $306M | $200M | $246M | $298M | $337M | $219M | $228M | $250M | $266M | $59M | $57M | $78M | $96M | $136M | |
| Liabilities + Equity | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Shares Outstanding | 84,981,843 | 83,453,001 | 82,826,416 | 69,569,813 | 68,889,649 | 68,811,357 | 68,266,005 | 53,524,364 | 52,160,305 | 49,885,701 | 49,043,074 | 35,309,432 | 34,306,118 | 34,301,926 | 34,082,934 | 34,072,155 |
현금 흐름 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $690.0K | $636.0K | $698.0K | $576.0K | $538.0K | $497.0K | $467.0K | $408.0K | $362.0K | $303.0K | $112.0K | · | · | · | · | · | |
| Stock-based Comp | $10M | $12M | $7M | $6M | $7M | $8M | $8M | $7M | $9M | $13M | $4M | $4M | $2M | $3M | $3M | $3M | |
| Deferred Tax | · | · | $369.0K | $0 | · | · | $90.0K | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $205.0K | $615.0K | |
| Other Non-cash | · | $-8M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-81M | $-65M | $-59M | $-63M | $-53M | $-36M | $-39M | $-20M | $-31M | $-23M | $-15M | $57M | $-17M | $-13M | $-13M | |
| CapEx | $1M | $997.0K | $986.0K | $798.0K | $1M | $276.0K | $384.0K | $2M | $900.0K | $1M | $883.0K | $2M | $396.0K | $484.0K | $585.0K | $1M | |
| Investing Cash Flow | $75M | $59M | $-75M | $55M | $48M | $40M | $-96M | $16M | $-160M | $21M | $-47M | $-2M | $13M | $32M | $33M | $6M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $167M | $7M | · | · | $152M | · | · | · | $216M | · | · | · | $0 | · | |
| Financing Cash Flow | $20M | $-3M | $167M | $7M | $238.0K | $-951.0K | $152M | $12M | $329.0K | $115.0K | $218M | $10M | $-37M | $-5M | $-58.0K | $92.0K | |
| Net Change in Cash | $33M | $-24M | $27M | $3M | $-14M | $-15M | $20M | $-11M | $-180M | $-10M | $148M | $-7M | $34M | $10M | $20M | $-7M | |
| Free Cash Flow | · | $-82M | · | · | · | $-53M | · | · | · | $-32M | · | · | · | $-17M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -19207.1% | -12532.5% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| Net Margin | -18633.1% | -12188.5% | · | -6183.4% | -1114.3% | -184.8% | · | -279.0% | -325.3% | -250.6% | · | -83.0% | -251.7% | -275.5% | · | -184.0% | |
| Pretax Margin | -18633.1% | · | · | -6183.4% | -1112.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -19207.1% | -12441.1% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| ROA | -35.7% | -26.1% | · | -21.6% | -19.0% | -13.1% | · | -12.7% | -12.3% | -12.1% | · | -6.6% | -11.2% | -10.6% | · | -9.5% | |
| ROE | -45.8% | -32.1% | · | -28.5% | -25.1% | -16.5% | · | -21.2% | -21.6% | -17.8% | · | -12.9% | -22.0% | -17.3% | · | -16.1% | |
| ROIC | -58.5% | · | · | -31.0% | -25.3% | · | · | · | · | · | · | · | · | · | · | · |
유동성 및 지급능력 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.7 | · | 7.2 | 8.0 | 7.8 | · | 5.5 | 4.7 | 5.1 | · | 2.4 | 2.4 | 5.4 | · | 5.6 | |
| Quick Ratio | 4.3 | 5.9 | · | 6.8 | 7.7 | 7.6 | · | 5.2 | 4.5 | 4.8 | · | 2.1 | 2.1 | 4.5 | · | 4.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -52.3 | -26.5 | · | -27.8 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.2 | 0.4 | 0.2 | · | · | · | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $31M | · | $41M | $50M | $56M | · | $47M | $45M | $44M | · | $42M | $38M | $39M | · | $40M | |
| Net Income TTM | $-298M | $-249M | · | $-194M | $-165M | $-135M | · | $-102M | $-96M | $-86M | · | $-75M | $-82M | $-80M | · | $-75M | |
| Market Cap | $1.22B | $1.08B | · | $991M | $648M | $373M | · | $428M | $454M | $1.03B | · | $282M | $298M | $101M | · | $270M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $146M | $156M | $13M | · | $152M | |
| P/E | -3.8 | -3.9 | · | -4.9 | -3.6 | -2.3 | · | -4.0 | -4.2 | -10.1 | · | -4.0 | -4.0 | -1.4 | · | -3.7 | |
| P/S | 162.0 | 34.2 | · | 24.0 | 13.0 | 6.6 | · | 9.1 | 10.0 | 23.6 | · | 6.7 | 7.8 | 2.6 | · | 6.7 | |
| P/B | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.0 | |
| P / Tangible Book | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -7.0 | · | · | · | -33.1 | · | · | · | -6.0 | · | · | |
| P / FCF | · | -13.2 | · | · | · | -7.0 | · | · | · | -31.9 | · | · | · | -5.8 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -10.1 | -6.9 | -0.6 | · | -8.3 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -0.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 3.5 | 4.1 | 0.3 | · | 3.8 | |
| Earnings Yield | -26.4% | -25.9% | · | -20.3% | -27.8% | -42.8% | · | -25.0% | -23.8% | -9.9% | · | -24.9% | -25.1% | -72.5% | · | -27.2% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $31M | $43M | $46M | $41M | $37M |
| 영업이익률 % | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% |
| 순이익 | $-232M | $-131M | $-71M | $-102M | $-58M |
| 희석 EPS | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | — | — | 0.0 | 0.4 | 0.2 |
| 유동비율 | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 |
| 당좌 비율 | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-243M | $-130M | $-2M | $-67M | $-50M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 217개의 제출자 · $1.2B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 37 (-18 이전 분기 대비) | 20 (-3 이전 분기 대비) | 63 (-9 이전 분기 대비) | 56 (+18 이전 분기 대비) | +8.5M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $118,638,163 | 8,296,375 | 10.19% | 주식 |
| Cormorant Asset Management, LP | $100,100,000 | 7,000,000 | 8.60% | 주식 |
| VANGUARD GROUP INC | $78,353,343 | 4,288,634 | 6.73% | 주식 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $69,037,426 | 4,827,792 | 5.93% | 주식 |
| Commodore Capital LP | $65,780,000 | 4,600,000 | 5.65% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $51,912,604 | 3,630,252 | 4.46% | 주식 |
| JANUS HENDERSON GROUP PLC | $45,962,750 | 3,565,768 | 3.95% | 주식 |
| Paradigm Biocapital Advisors LP | $41,332,677 | 2,890,397 | 3.55% | 주식 |
| STATE STREET CORP | $33,712,894 | 2,357,545 | 2.90% | 주식 |
| Aberdeen Group plc | $28,725,869 | 2,008,802 | 2.47% | 주식 |
| PERCEPTIVE ADVISORS LLC | $28,600,000 | 2,000,000 | 2.46% | 풋 옵션 |
| Balyasny Asset Management L.P. | $25,916,719 | 1,812,358 | 2.23% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $25,269,659 | 1,766,745 | 2.17% | 주식 |
| CITADEL ADVISORS LLC | $25,214,389 | 1,763,244 | 2.17% | 주식 |
| Parkman Healthcare Partners LLC | $18,420,731 | 1,288,163 | 1.58% | 주식 |
| EVENTIDE ASSET MANAGEMENT, LLC | $17,811,837 | 1,245,583 | 1.53% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $16,890,345 | 1,181,143 | 1.45% | 주식 |
| Essex Woodlands Management, Inc. | $15,513,455 | 1,084,857 | 1.33% | 주식 |
| ORBIMED ADVISORS LLC | $15,288,802 | 1,069,147 | 1.31% | 주식 |
| 5AM Venture Management, LLC | $15,015,000 | 1,050,000 | 1.29% | 주식 |
| Rosalind Advisors, Inc. | $14,131,689 | 988,230 | 1.21% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13,885,500 | 971,014 | 1.19% | 주식 |
| HSBC HOLDINGS PLC | $11,918,407 | 833,455 | 1.02% | 주식 |
| Candriam S.C.A. | $11,254,258 | 787,769 | 0.97% | 주식 |
| AMERIPRISE FINANCIAL INC | $11,087,640 | 775,357 | 0.95% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $11,062,981 | 773,635 | 0.95% | 주식 |
| Artia Global Partners LP | $10,969,501 | 767,098 | 0.94% | 주식 |
| Blue Owl Capital Holdings LP | $10,905,094 | 762,594 | 0.94% | 주식 |
| Patient Square Capital LP | $10,296,000 | 720,000 | 0.88% | 주식 |
| Principia Wealth Advisory, LLC | $9,696,346 | 530,725 | 0.83% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9,260,866 | 647,613 | 0.80% | 주식 |
| Sio Capital Management, LLC | $8,910,759 | 623,130 | 0.77% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $7,996,789 | 559,216 | 0.69% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7,899,320 | 552,400 | 0.68% | 콜 옵션 |
| Alyeska Investment Group, L.P. | $7,284,463 | 509,403 | 0.63% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $7,151,330 | 500,093 | 0.61% | 주식 |
| Simplify Asset Management Inc. | $5,720,629 | 400,044 | 0.49% | 주식 |
| Ikarian Capital, LLC | $5,296,720 | 370,400 | 0.46% | 콜 옵션 |
| Ikarian Capital, LLC | $5,296,720 | 370,400 | 0.46% | 풋 옵션 |
| Ghisallo Capital Management LLC | $5,005,000 | 350,000 | 0.43% | 주식 |
| STEMPOINT CAPITAL LP | $4,840,135 | 338,471 | 0.42% | 주식 |
| E Fund Management Co., Ltd. | $4,730,068 | 330,774 | 0.41% | 주식 |
| Jump Financial, LLC | $4,586,825 | 320,757 | 0.39% | 주식 |
| Bleichroeder LP | $4,526,165 | 316,515 | 0.39% | 주식 |
| Woodline Partners LP | $4,296,621 | 300,463 | 0.37% | 주식 |
| Eversept Partners, LP | $4,257,610 | 297,735 | 0.37% | 주식 |
| GOLDMAN SACHS GROUP INC | $4,086,797 | 285,790 | 0.35% | 주식 |
| Rock Springs Capital Management LP | $3,839,822 | 268,519 | 0.33% | 주식 |
| CITIGROUP INC | $3,750,032 | 262,240 | 0.32% | 주식 |
| MYDA Advisors LLC | $3,575,000 | 250,000 | 0.31% | 주식 |
| AXA Investment Managers S.A. | $3,480,640 | 244,427 | 0.30% | 주식 |
| UBS Group AG | $3,373,442 | 235,905 | 0.29% | 주식 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3,342,639 | 233,751 | 0.29% | 주식 |
| Schonfeld Strategic Advisors LLC | $3,285,853 | 229,780 | 0.28% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3,038,750 | 212,500 | 0.26% | 풋 옵션 |
| Propel Bio Management, LLC | $2,741,954 | 191,745 | 0.24% | 주식 |
| Qube Research & Technologies Ltd | $2,704,159 | 189,102 | 0.23% | 주식 |
| Walleye Capital LLC | $2,691,560 | 188,221 | 0.23% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $2,685,554 | 187,801 | 0.23% | 주식 |
| BlackRock, Inc. | $2,649,890 | 185,307 | 0.23% | 주식 |
| CITADEL ADVISORS LLC | $2,559,700 | 179,000 | 0.22% | 풋 옵션 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2,389,303 | 169,334 | 0.21% | 주식 |
| HighVista Strategies LLC | $2,226,567 | 155,704 | 0.19% | 주식 |
| Granahan Investment Management, LLC | $2,136,234 | 149,387 | 0.18% | 주식 |
| Swiss National Bank | $2,034,890 | 142,300 | 0.17% | 주식 |
| STATE OF WISCONSIN INVESTMENT BOARD | $1,998,711 | 139,770 | 0.17% | 주식 |
| PANAGORA ASSET MANAGEMENT INC | $1,890,660 | 132,214 | 0.16% | 주식 |
| Corient Private Wealth LP | $1,827,526 | 127,799 | 0.16% | 주식 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $1,740,081 | 121,684 | 0.15% | 주식 |
| BOOTHBAY FUND MANAGEMENT, LLC | $1,548,690 | 108,300 | 0.13% | 콜 옵션 |
| BOOTHBAY FUND MANAGEMENT, LLC | $1,548,690 | 108,300 | 0.13% | 풋 옵션 |
| DIADEMA PARTNERS LP | $1,520,090 | 106,300 | 0.13% | 콜 옵션 |
| SILVERBACK ASSET MANAGEMENT LLC | $1,430,000 | 100,000 | 0.12% | 콜 옵션 |
| Squarepoint Ops LLC | $1,401,429 | 98,002 | 0.12% | 주식 |
| RHUMBLINE ADVISERS | $1,393,341 | 97,437 | 0.12% | 주식 |
| CITADEL ADVISORS LLC | $1,357,070 | 94,900 | 0.12% | 콜 옵션 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1,354,752 | 105,101 | 0.12% | 주식 |
| ALGERT GLOBAL LLC | $1,129,557 | 78,990 | 0.10% | 주식 |
| Waverly Advisors, LLC | $1,114,170 | 77,914 | 0.10% | 주식 |
| Cinctive Capital Management LP | $1,037,923 | 72,582 | 0.09% | 주식 |
| Caption Management, LLC | $1,036,750 | 72,500 | 0.09% | 콜 옵션 |
| WELLINGTON MANAGEMENT GROUP LLP | $1,035,134 | 72,387 | 0.09% | 주식 |
| GOLDMAN SACHS GROUP INC | $1,002,430 | 70,100 | 0.09% | 콜 옵션 |
| DEUTSCHE BANK AG\ | $989,860 | 69,221 | 0.09% | 주식 |
| Bank of New York Mellon Corp | $981,824 | 68,659 | 0.08% | 주식 |
| WOODSTOCK CORP | $979,049 | 68,465 | 0.08% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $971,081 | 75,336 | 0.08% | 주식 |
| BANK OF AMERICA CORP /DE/ | $930,186 | 65,048 | 0.08% | 주식 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $865,708 | 60,539 | 0.07% | 주식 |
| FOX RUN MANAGEMENT, L.L.C. | $836,950 | 58,528 | 0.07% | 주식 |
| Y-Intercept (Hong Kong) Ltd | $732,017 | 51,190 | 0.06% | 주식 |
| SILVERBACK ASSET MANAGEMENT LLC | $715,000 | 50,000 | 0.06% | 주식 |
| JANE STREET GROUP, LLC | $715,000 | 50,000 | 0.06% | 콜 옵션 |
| Erste Asset Management GmbH | $705,500 | 50,000 | 0.06% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $702,545 | 49,129 | 0.06% | 주식 |
| Point72 Asset Management, L.P. | $694,608 | 48,574 | 0.06% | 주식 |
| SBI Okasan Asset Management Co.Ltd. | $644,827 | 45,700 | 0.06% | 주식 |
| MetLife Investment Management, LLC | $621,607 | 43,469 | 0.05% | 주식 |
| JANE STREET GROUP, LLC | $597,954 | 41,815 | 0.05% | 주식 |
| SCOTIA CAPITAL INC. | $597,039 | 41,751 | 0.05% | 주식 |
회사 내부자 25 명의 내부자 · 12 임원 · 16 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Jay S. Duker | President and CEO | 2026년 7월 10일 M | 9,594 | 0 | 0 | $0 |
| Nancy Lurker | President & CEO | 2018년 10월 12일 A | 211,700 | 0 | 0 | $0 |
| Paul Ashton | President & CEO | 2016년 3월 18일 M | 450,741 | 0 | 0 | $0 |
| David Price | Chief Financial Officer | 2018년 8월 1일 A | — | 0 | 0 | $0 |
| Michael Soja | VP Finance, CFO & Treasurer | 2008년 9월 10일 A | — | 0 | 0 | $0 |
| Ramiro Ribeiro | Chief Medical Officer | 2026년 6월 30일 M | 0 | 0 | 2 | $-73,174 |
| Leonard S Ross | Vice President of Finance and Chief Accounting Officer | 2018년 12월 22일 M | 76,187 | 0 | 0 | $0 |
| Dario A. Paggiarino | Chief Medical Officer | 2018년 10월 12일 F | 29,600 | 0 | 0 | $0 |
| Leonard M Blum | Executive VP and General Manager, US | 2018년 5월 14일 A | — | 0 | 0 | $0 |
| Debora Jorn | EVP, Corp. & Comm'l Dev. | 2017년 6월 27일 A | — | 0 | 0 | $0 |
| Lori Freedman | VP Corporate Affairs, General Counsel and Secretary | 2016년 7월 21일 A | 96,423 | 0 | 0 | $0 |
| Aaron Finlay | Secretary | 2007년 10월 18일 A | — | 0 | 0 | $0 |
| Karen L. Zaderej | 이사 | 2026년 8월 18일 P | 49,100 | 1 | 0 | $52,258 |
| Wendy F Dicicco | 이사 | 2026년 1월 2일 A | — | 0 | 0 | $0 |
| ANDO GORAN | 이사 | 2026년 1월 2일 A | — | 0 | 0 | $0 |
| Fred Hassan | 이사 | 2026년 1월 2일 A | — | 0 | 0 | $0 |
| Michael W Rogers | 이사 | 2018년 11월 15일 M | 112,500 | 0 | 0 | $0 |
| John B. Landis | 이사 | 2018년 10월 25일 A | — | 0 | 0 | $0 |
| David J Mazzo | 이사 | 2018년 9월 6일 A | 138,000 | 0 | 0 | $0 |
| Douglas Evan Godshall | 이사 | 2018년 6월 27일 M | 12,500 | 0 | 0 | $0 |
| James J Barry | 이사 | 2018년 5월 7일 M | 12,500 | 0 | 0 | $0 |
| Kristine Peterson | 이사 | 2017년 12월 15일 A | — | 0 | 0 | $0 |
| SAVAS PETER G | 이사 | 2015년 12월 3일 A | — | 0 | 0 | $0 |
| Paul Hopper | 이사 | 2013년 12월 18일 A | 10,000 | 0 | 0 | $0 |
| Katherine Woodthorpe | 이사 | 2007년 11월 27일 A | — | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 5 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| EW Healthcare Partners L.P., EW Healthcare Partners-A L.P., Essex Woodlands Fund IX-GP, L.P., Essex Woodlands IX, LLC, Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio, Steve Wiggins ×4 제출 서류 | 2023년 12월 8일 | — | 최초 제출 | — | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2023년 8월 30일 | — | 최초 제출 | — | SEC |
| Ocumension Therapeutics | 2021년 1월 22일 | — | 최초 제출 | — | SEC |
| IRS Identification Nos. of above persons (entities only) Pfizer Inc. ×2 제출 서류 | 2017년 5월 26일 | — | 최초 제출 | — | SEC |
| Pfizer Inc. | 2007년 7월 17일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 42 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1.18% | 11,564 NS | 2026년 4월 30일 | N-PORT |
| BBC · ETFis Series Trust I | 0.61% | 17,260 NS | 2026년 4월 30일 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.51% | 8,244 SH | 2026년 8월 8일 | 일간 |
| IWC · iShares Trust | 0.23% | 262,360 SH | 2026년 8월 8일 | 일간 |
| IHE · iShares Trust | 0.22% | 281,199 SH | 2026년 8월 8일 | 일간 |
| FSCC · Federated Hermes ETF Trust | 0.12% | 25,180 NS | 2026년 5월 31일 | N-PORT |
| NUSC · Nushares ETF Trust | 0.08% | 78,250 NS | 2026년 4월 30일 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.08% | 4,561 SH | 2026년 8월 8일 | 일간 |
| VFMO · VANGUARD WELLINGTON FUND | 0.06% | 86,797 SH | 2026년 8월 8일 | 일간 |
| BIB · ProShares Trust | 0.06% | 3,062 NS | 2026년 5월 31일 | N-PORT |
| IWO · iShares Trust | 0.05% | 592,383 SH | 2026년 8월 8일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.05% | 69,310 SH | 2026년 8월 8일 | 일간 |
| GSSC · Goldman Sachs ETF Trust | 0.04% | 25,575 NS | 2026년 5월 31일 | N-PORT |
| IWM · iShares Trust | 0.03% | 1,980,136 SH | 2026년 8월 8일 | 일간 |
| RSSL · Global X Funds | 0.03% | 33,518 NS | 2026년 4월 30일 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 445,218 SH | 2026년 8월 8일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.03% | 61,360 SH | 2026년 8월 8일 | 일간 |
| ISCV · iShares Trust | 0.03% | 15,627 SH | 2026년 8월 8일 | 일간 |
| ITWO · ProShares Trust | 0.03% | 3,648 NS | 2026년 5월 31일 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.02% | 378,469 NS | 2026년 5월 31일 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 34,174 NS | 2026년 4월 30일 | N-PORT |
| UWM · ProShares Trust | 0.02% | 2,853 NS | 2026년 5월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 152,391 NS | 2026년 4월 30일 | N-PORT |
| ISCB · iShares Trust | 0.01% | 3,155 SH | 2026년 8월 8일 | 일간 |
| URTY · ProShares Trust | 0.01% | 2,885 NS | 2026년 5월 31일 | N-PORT |
| IWN · iShares Trust | 0.01% | 120,933 SH | 2026년 8월 8일 | 일간 |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 901,417 SH | 2026년 8월 8일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 11,210 SH | 2026년 8월 8일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.01% | 213,549 SH | 2026년 8월 8일 | 일간 |
| WSML · iShares Trust | 0.01% | 4,526 SH | 2026년 8월 8일 | 일간 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 2,895 NS | 2026년 5월 31일 | N-PORT |
| HDG · ProShares Trust | 0.00% | 72 NS | 2026년 5월 31일 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.00% | 28,026 NS | 2026년 5월 31일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 3,564 NS | 2026년 4월 30일 | N-PORT |
| ITOT · iShares Trust | 0.00% | 111,667 SH | 2026년 8월 8일 | 일간 |
| IWV · iShares Trust | 0.00% | 21,976 SH | 2026년 8월 8일 | 일간 |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 46,188 NS | 2026년 5월 31일 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 10,667 NS | 2026년 4월 30일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 41,879 NS | 2026년 4월 30일 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 13,282 NS | 2026년 4월 30일 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,643,860 SH | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 6,035 SH | 2026년 8월 8일 | 일간 |